LifeStance Health Group, Inc. Capital Expenditures
LifeStance Health Group, Inc. (LFST) reported Capital Expenditures of $22.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $11.99M, a 54.66% increase year-over-year.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $10.77M, a 50.21% increase year-over-year.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $10.91M, a 73.16% increase year-over-year.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $10.29M, a 103.74% increase year-over-year.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $36.13M, a 67.51% increase from fiscal 2024.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $21.57M, a 46.78% decline from fiscal 2023.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $40.52M, a 48.87% decline from fiscal 2022.
- LifeStance Health Group, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $79.25M, a 16.13% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 4 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $11.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $22.76M 10-Q · filed 2026-08-06 | $33.67M derived: sum of 3 quarters · filed 2026-08-06 | $43.96M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $10.77M 10-Q · filed 2026-05-07 | $21.68M derived: sum of 2 quarters · filed 2026-05-07 | $31.97M derived: sum of 3 quarters · filed 2026-05-07 | $39.72M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $10.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $21.20M derived: sum of 2 quarters · filed 2026-02-25 | $28.96M derived: sum of 3 quarters · filed 2026-08-06 | $36.13M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $10.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $18.05M derived: sum of 2 quarters · filed 2026-08-06 | $25.21M 10-Q · filed 2025-11-06 | $31.52M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $7.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.92M 10-Q · filed 2026-08-06 | $21.22M derived: sum of 3 quarters · filed 2026-08-06 | $26.27M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $7.17M 10-Q · filed 2026-05-07 | $13.47M derived: sum of 2 quarters · filed 2026-05-07 | $18.52M derived: sum of 3 quarters · filed 2026-05-07 | $23.63M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.35M derived: sum of 2 quarters · filed 2026-02-25 | $16.46M derived: sum of 3 quarters · filed 2026-02-25 | $21.57M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.16M derived: sum of 2 quarters · filed 2025-11-06 | $15.27M 10-Q · filed 2025-11-06 | $26.68M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $5.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.21M 10-Q · filed 2025-08-07 | $21.63M derived: sum of 3 quarters · filed 2026-02-25 | $31.42M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $5.10M 10-Q · filed 2025-05-07 | $16.52M derived: sum of 2 quarters · filed 2026-02-25 | $26.31M derived: sum of 3 quarters · filed 2026-02-25 | $37.90M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $11.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $21.21M derived: sum of 2 quarters · filed 2026-02-25 | $32.79M derived: sum of 3 quarters · filed 2026-02-25 | $40.52M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $21.38M derived: sum of 2 quarters · filed 2024-11-07 | $29.11M 10-Q · filed 2024-11-07 | $39.49M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $11.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $19.31M 10-Q · filed 2024-08-08 | $29.69M derived: sum of 3 quarters · filed 2025-02-27 | $44.79M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $7.73M 10-Q · filed 2024-05-09 | $18.11M derived: sum of 2 quarters · filed 2025-02-27 | $33.21M derived: sum of 3 quarters · filed 2025-02-27 | $59.07M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $25.48M derived: sum of 2 quarters · filed 2025-02-27 | $51.34M derived: sum of 3 quarters · filed 2025-02-27 | $79.25M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $40.96M derived: sum of 2 quarters · filed 2023-11-08 | $68.87M 10-Q · filed 2023-11-08 | $107.55M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $25.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $53.77M 10-Q · filed 2023-08-09 | $92.45M derived: sum of 3 quarters · filed 2024-02-28 | $116.46M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $27.91M 10-Q · filed 2023-05-10 | $66.59M derived: sum of 2 quarters · filed 2024-02-28 | $90.60M derived: sum of 3 quarters · filed 2024-02-28 | $111.32M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $38.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $62.69M derived: sum of 2 quarters · filed 2024-02-28 | $83.41M derived: sum of 3 quarters · filed 2024-02-28 | $94.49M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $24.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $44.73M derived: sum of 2 quarters · filed 2022-11-09 | $55.81M 10-Q · filed 2022-11-09 | $66.42M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | $20.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $31.80M 10-Q · filed 2022-08-10 | $42.41M derived: sum of 3 quarters · filed 2023-03-09 | $51.95M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | $11.08M 10-Q · filed 2022-05-11 | $21.69M derived: sum of 2 quarters · filed 2023-03-09 | $31.22M derived: sum of 3 quarters · filed 2023-03-09 | $36.34M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | $10.61M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $20.14M derived: sum of 2 quarters · filed 2023-03-09 | $25.26M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $9.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | $14.65M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $5.12M 10-Q · filed 2021-08-12 | ||||
| 2020-05-14 | $12.80M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $14.31M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |